Conestat alfa (Ruconest): First recombinant C1 esterase inhibitor for the treatment of acute attacks in patients with hereditary angioedema

P and T

Volumn 40, Issue 2, 2015, Pages

  Cruz, Martin Paspe ^a,b,c,d,e  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HAMPTON UNIVERSITY   (United States)

^c Eastern Virginia School of Medicine   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e Caspi and Associates in New York   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C1S INHIBITOR; FIBRIN;

ABDOMINAL PAIN; ANAPHYLAXIS; ANATOMICAL VARIATION; ANGIONEUROTIC EDEMA; BACKACHE; BLOOD VESSEL PERMEABILITY; CHEST TIGHTNESS; DIARRHEA; HEADACHE; HUMAN; HYPOTENSION; IMMUNOGENICITY; LIPOMA; MAXIMUM PLASMA CONCENTRATION; NAUSEA; NOTE; PHARMACODYNAMICS; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; SIMULATION; SKIN BURNING SENSATION; URTICARIA; VERTIGO; WHEEZING;

EID: 84922794307     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (19)

1. Buyantseva LV, Sardana N, Craig TJ. Update on treatment of hereditary angioedema. Asian Pac J Allergy Immunol 2012;30(2):89–98.
2. Bork K. Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor. Allergy Asthma Clin Immunol 2010;6(1):15. doi:10.1186/1710-1492-6-15.
3. Kaplan A. Type III hereditary angioedema: defined, but not understood. Ann Allergy Asthma Immunol 2012;109(3):153–154. doi: 10.1016/j.anai.2012.07.007.
4. Kittisupamongkol W. Normal C1 inhibitor hereditary angioedema. Am J Med 2009;122(5):e7. doi: 10.1016/j.amjmed.2008.11.011.
5. Marx J, Hockberger R, Walls R. Urticaria and angioedema. In: Marx J, Hockberger R, Walls R., Rosen’s Emergency Medicine. 7th ed. Philadelphia, Pennsylvania: Mosby; 2009.
6. Simons FE. Emergency treatment of anaphylaxis. BMJ 2008;336(7654):1141–1142.
7. Ruconest prescribing information. Salix Pharmaceuticals Inc.; Raleigh, North Carolina; 2014.
8. Firazyr prescribing information. Lexington, Massachusetts; Shire Orphan Therapies, Inc.; 2011.
9. Lehmann A. Ecallantide (DX-88), a plasma kallikrein inhibitor for the treatment of hereditary angioedema and the prevention of blood loss in on-pump cardiothoracic surgery. Expert Opin Biol Ther 8(8):187:199.
10. Jerini AG. Jerini receives European Commission approval for Firazyr (icatibant) in the treatment of HAE. July 15, 2008. Accessed December 12, 2014.
11. Bernstein JA. Hereditary angioedema: a current state-of-the-art review, VIII: current status of emerging therapies. Ann Allergy Asthma Immunol 2008;100(1 suppl 2):S41–S46.
12. Cinryze (C1 inhibitor [human]) prescribing information. New York, New York; Lev Pharmaceuticals Inc.; October 2008.
13. Berinert (C1 esterase inhibitor [human]) prescribing information. Kankakee, Illinois; CSL Behring; October 2009.
14. Kalbitor (plasma kallikrein inhibitor [human]) prescribing information. Burlington, Massachusetts; Dyax Corp.; December 2009.
15. Caliezi C, Wuillemin WA, Zeerleder S, et al. C1-esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema. Pharmacol Rev 2000; 52(1):91–112.
16. Van Doorn MB, Burggraaf J, van Dam T, et al. A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema. J Allergy Clin Immunol 2005;116(4):876–883.
17. Relan A, Haase G, Pijpstra R, et al. Dose justification for recombinant human C1INH for the treatment of acute angioedema attacks in patients with hereditary angioedema. Poster presented at the 29th European Academy of Allergy and Clinical Immunology Congress, June 5–9, 2010, London, United Kingdom.
18. Kawalec P, Holko P, Paszulewicz A. Cost-utility analysis of Ruconest (conestat alfa) compared to Berinert P (human C1 esterase inhibitor) in the treatment of acute, life-threatening angioedema attacks in patients with hereditary angioedema. Postepy Dermatol Alergol 2013;30(3):152–158.
19. Red Book Online. Ann Arbor, Michigan; Truven Health Analytics. Accessed December 30, 2014.